Release Date: 19/08/14 19:09 Summary: Bidders Statement - Off-market bid from MTE Price Sensitive: No Download Document 6.17MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%